PLoS ONE (Jan 2014)

Staurosporine and extracellular matrix proteins mediate the conversion of small cell lung carcinoma cells into a neuron-like phenotype.

  • Tamara Murmann,
  • Carmen Carrillo-García,
  • Nadine Veit,
  • Cornelius Courts,
  • Alexander Glassmann,
  • Viktor Janzen,
  • Burkhard Madea,
  • Markus Reinartz,
  • Anne Harzen,
  • Michael Nowak,
  • Sven Perner,
  • Jochen Winter,
  • Rainer Probstmeier

DOI
https://doi.org/10.1371/journal.pone.0086910
Journal volume & issue
Vol. 9, no. 2
p. e86910

Abstract

Read online

Small cell lung carcinomas (SCLCs) represent highly aggressive tumors with an overall five-year survival rate in the range of 5 to 10%. Here, we show that four out of five SCLC cell lines reversibly develop a neuron-like phenotype on extracellular matrix constituents such as fibronectin, laminin or thrombospondin upon staurosporine treatment in an RGD/integrin-mediated manner. Neurite-like processes extend rapidly with an average speed of 10 µm per hour. Depending on the cell line, staurosporine treatment affects either cell cycle arrest in G2/M phase or induction of polyploidy. Neuron-like conversion, although not accompanied by alterations in the expression pattern of a panel of neuroendocrine genes, leads to changes in protein expression as determined by two-dimensional gel electrophoresis. It is likely that SCLC cells already harbour the complete molecular repertoire to convert into a neuron-like phenotype. More extensive studies are needed to evaluate whether the conversion potential of SCLC cells is suitable for therapeutic interventions.